A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

Status:
Completed

Trial end date:
2008-11-01

Target enrollment:

Participant gender:

Study of whether the investigational drug CE-326,597 improves glucose control and results in body weight loss in patients with type 2 diabetes

Phase 2

Pfizer